What is the recommended antimicrobial regimen for concurrent chlamydia and gonorrhea infection in a sexually active adult?

Treating Concurrent Chlamydia and Gonorrhea

For concurrent chlamydia and gonorrhea infection in sexually active adults, administer ceftriaxone 500 mg intramuscularly as a single dose PLUS doxycycline 100 mg orally twice daily for 7 days. 1, 2, 3

Primary Treatment Regimen

The CDC's 2021 STI Treatment Guidelines represent a critical shift from previous dual therapy with azithromycin, driven by rising azithromycin resistance (nearly 5% of isolates by 2018) and antimicrobial stewardship concerns. 2, 3

Recommended regimen:

• Ceftriaxone 500 mg IM single dose (1 g if patient weighs ≥150 kg) 1, 2, 3, 4
• PLUS doxycycline 100 mg orally twice daily for 7 days 1, 2, 3, 5

This combination addresses both pathogens effectively: ceftriaxone achieves 99.1% cure for gonorrhea at all anatomic sites (urogenital, anorectal, and pharyngeal), while doxycycline is now the preferred chlamydia treatment over azithromycin. 1, 2, 5

Rationale for Current Regimen

Why ceftriaxone monotherapy for gonorrhea:

• Ceftriaxone remains the only highly effective antimicrobial for gonorrhea with stable MICs in the United States (<0.1% showing "alert value" MIC >0.25 mcg/mL) 2, 4
• The increased dose from 250 mg to 500 mg provides a therapeutic reserve against emerging resistance 1, 2, 3
• No ceftriaxone-resistant strains have been reported in the United States 1

Why doxycycline over azithromycin for chlamydia:

• Azithromycin resistance in gonorrhea has risen rapidly (≥2.0 mcg/mL MIC in nearly 5% of isolates by 2018) 2
• Antimicrobial stewardship principles favor avoiding azithromycin to preserve its effectiveness 2, 3
• Doxycycline is the preferred first-line chlamydia treatment in current guidelines 5

Alternative Regimens

When ceftriaxone is unavailable:

• Cefixime 400 mg orally single dose PLUS azithromycin 1 g orally single dose 1, 6
• Mandatory test-of-cure at 1 week is required with this regimen 1, 6
• Cefixime achieves only 97.4% cure for urogenital/anorectal gonorrhea and 78.9% for pharyngeal infections, significantly lower than ceftriaxone 1

For severe cephalosporin allergy:

• Azithromycin 2 g orally single dose PLUS doxycycline 100 mg orally twice daily for 7 days 1, 7
• Mandatory test-of-cure at 1 week 1, 7
• This regimen has lower efficacy (≈93%) and high gastrointestinal side effects 1
• Gentamicin 240 mg IM single dose PLUS azithromycin 2 g orally single dose achieved 100% cure in trials, but pharyngeal efficacy is poor (only 20% in one study) 1

Special Populations

Pregnant patients:

• Ceftriaxone 500 mg IM single dose PLUS azithromycin 1 g orally single dose 1
• Never use doxycycline, quinolones, or tetracyclines in pregnancy due to fetal safety concerns 1, 5
• If severe cephalosporin allergy: spectinomycin 2 g IM PLUS azithromycin 1 g orally 1

Men who have sex with men (MSM):

• Use the same ceftriaxone-based regimen 1
• Never use quinolones due to higher prevalence of resistant strains 1
• Do not use expedited partner therapy in MSM due to high risk of undiagnosed coexisting STDs or HIV 1

HIV-infected patients:

• Receive the same treatment regimen as HIV-negative patients 6
• Treatment is particularly vital because cervicitis increases cervical HIV shedding and may facilitate HIV transmission 6

Partner Management

All sexual partners from the preceding 60 days must be evaluated and treated immediately, regardless of symptoms or test results. 1, 6

Timing-based criteria:

• Symptomatic index patient: Treat every partner whose last contact occurred ≤30 days before symptom onset 1
• Asymptomatic index patient: Treat every partner whose last contact occurred ≤60 days before diagnosis 1
• If the last contact predates these windows, treat the most recent partner 1

Partner treatment regimen:

• Same dual therapy as index patient: ceftriaxone 500 mg IM PLUS doxycycline 100 mg orally twice daily for 7 days 1
• For pregnant partners: ceftriaxone 500 mg IM PLUS azithromycin 1 g orally 1

Expedited partner therapy (EPT):

• Consider cefixime 400 mg orally PLUS azithromycin 1 g orally if partners cannot be linked to timely evaluation 1
• Do not use EPT in MSM due to high risk of undiagnosed coexisting STDs or HIV 1
• Female partners receiving EPT must be counseled to seek clinical evaluation for possible pelvic inflammatory disease 1

Sexual activity restrictions:

• Patients and all partners must abstain from sexual intercourse until therapy is completed (7 days after single-dose regimen or after completion of 7-day doxycycline) and all individuals are asymptomatic 1, 6

Follow-Up and Test-of-Cure

Routine test-of-cure is NOT required for patients treated with the recommended ceftriaxone-based regimen unless symptoms persist. 1, 5

Mandatory test-of-cure at 1 week is required for:

• Patients treated with cefixime-based regimens 1, 6
• Patients treated with azithromycin monotherapy for gonorrhea 1, 7
• All cases of pharyngeal gonorrhea 5
• Rectal chlamydia if treated with azithromycin 5

Retesting at 3 months:

• Consider retesting all patients at 3 months due to high reinfection risk (20-30%) 1
• Most post-treatment positive tests represent reinfection rather than treatment failure 1

If symptoms persist after treatment:

• Obtain culture with antimicrobial susceptibility testing from all potentially infected sites 1, 6, 7
• Report the case to CDC through local or state health department within 24 hours 1, 7
• Consult an infectious disease specialist 1, 7

Site-Specific Considerations

Pharyngeal infections:

• Pharyngeal gonorrhea is significantly more difficult to eradicate than urogenital or anorectal infections 1
• Ceftriaxone 500 mg IM is the only reliably effective treatment for pharyngeal infections 1
• Oral cephalosporins achieve only 78.9% cure of pharyngeal infections 1
• Spectinomycin provides only 52% cure for pharyngeal gonorrhea 1
• The pharynx serves as a reservoir for antimicrobial-resistance development 1

Gonococcal conjunctivitis:

• Ceftriaxone 1 g IM single dose PLUS single saline eye lavage 1

Disseminated gonococcal infection (DGI):

• Hospitalization recommended for initial therapy 1
• Ceftriaxone 1 g IM or IV every 24 hours for 24-48 hours until clinical improvement 1
• Then switch to oral therapy to complete 1 week total treatment 1
• Assess for endocarditis and meningitis 1
• Provide presumptive treatment for concurrent chlamydial infection 1

Critical Pitfalls to Avoid

Never use fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin) for gonorrhea treatment due to widespread resistance, despite historical cure rates >99%. 1, 7, 5

Never use azithromycin 1 g alone for gonorrhea due to inadequate efficacy (only 93%) and risk of rapid resistance emergence. 1, 7

Never use cefixime as first-line therapy due to declining effectiveness, rising MICs, and limited efficacy for pharyngeal infections. 6, 7

Do not omit chlamydia treatment even when chlamydia testing is negative in a patient with gonorrhea, due to high co-infection rates (20-50% in males, up to 40-50% overall). 1

Do not assume symptom resolution equals cure when suboptimal regimens were used—test-of-cure is mandatory for alternative regimens. 1

Treatment Failure Management

If treatment failure is suspected:

• Obtain culture specimens immediately from all infected anatomic sites 7
• Perform phenotypic antimicrobial susceptibility testing using disk diffusion, Etest, or agar dilution 7
• Retain the isolate at the laboratory for possible further testing 7
• Report the case to CDC through local or state health department within 24 hours 7
• Consult an infectious disease specialist immediately 7

Re-treatment regimen for resistant cases:

• Ceftriaxone 500 mg IM PLUS azithromycin 2 g orally, both as single doses 7
• Alternative salvage regimens: gentamicin 240 mg IM PLUS azithromycin 2 g orally, or ertapenem 1 g IM for 3 days 1
• Conduct test-of-cure 1 week after re-treatment using culture (preferred) or NAAT 7
• Evaluate all sex partners from the preceding 60 days promptly with culture and treat as indicated 7

Additional Screening

At the time of gonorrhea diagnosis:

• Screen for syphilis with serology 1
• Perform HIV testing, as gonorrhea facilitates HIV transmission 1
• Assess for bacterial vaginosis and trichomoniasis in women with cervicitis, and treat if present 6